Can Steroids Cause Central Serous Chorioretinopathy?

The link is one of the steadier findings here. A pooled analysis of six comparison studies, covering 707 steroid users and 1,927 non-users, tied steroid use to about four times the odds of CSC². A separate review pooling 17 studies and 9,839 patients found a similar size of association⁷.

A Cochrane review calls steroid use the changeable risk factor reported most often for this condition⁸. These are observational comparisons, so they show a strong repeated link rather than lab-style proof of cause. Eye doctors treat it as solid enough to act on.

This is not only about tablets. Reported CSC cases have followed steroids taken by mouth or vein, sprayed in the nose, rubbed on the skin, injected into a joint, injected near the spine, and given around the eye³. Retina specialists name allergy nose sprays and skin creams, including ones sold without a prescription¹.

In the pooled analysis the link held for steroids by mouth, by injection, and by nose spray, while the result for inhaled steroids was not statistically clear². That does not clear inhalers, and it is no reason to skip an inhaler you rely on. The signal is simply weaker there.

Behind the retina sits a spongy bed of blood vessels called the choroid. In CSC this vessel layer becomes thickened and leaky while the pump cells above it stop clearing fluid, and steroid signaling is one of the pathways involved³.

Steroids are pushing on a system that controls blood vessels and fluid all over the body. The details are still being worked out, which is why no steroid dose is known to be safe or unsafe for the eye.

Steroid medicines copy a hormone your adrenal glands already make. CSC has also been linked to conditions where the body makes too much of its own cortisol, such as Cushing disease, and to pregnancy, when cortisol rises naturally³.

That parallel is part of why the steroid link is taken seriously. If CSC appears with no medicine to explain it, your doctor may ask about signs of high cortisol.

Steroids are not the only item on the list. The review of 17 studies also found links with high blood pressure, a stomach infection called Helicobacter pylori, poor sleep, autoimmune disease, some psychiatric medicines, and a driven, time-pressured personality style⁷.

Stimulants, decongestants, erectile dysfunction medicines, and some cancer drugs have been reported alongside CSC too¹. None of these makes a diagnosis by itself. They matter because they give you and your doctor a fuller list to review if fluid keeps coming back.

Doing nothing at first is an evidence-based choice, not a brush-off. Most sudden episodes resolve within three to six months³, and an evidence review concludes that observation may be preferred in sudden CSC, with treatment reserved for long-lasting disease¹⁰.

Watching still means being watched: you should leave with a follow-up date and clear instructions about what change brings you back sooner.

Your eye doctor will usually ask whether the steroid can be lowered, swapped, or stopped, and that question goes to whoever prescribed it. Steroid use is the changeable risk factor reported most often for CSC⁸, and stopping steroid treatment where that is possible is part of standard CSC management³.

What you should not do is stop it yourself. Adrenal insufficiency, where the body cannot make enough of its own cortisol, is common after steroids are discontinued, and no route, dose, or duration rules it out⁵. Dose reductions are therefore planned and monitored by the prescribing clinician⁶. Sometimes the steroid treats something that matters more than the fluid, and keeping it while watching the eye closely is a legitimate answer.

When fluid persists, the best-supported option is photodynamic therapy: a light-sensitive drug given by vein, then activated by a gentle laser aimed at the leaky vessel layer. An evidence review names half-dose or half-strength photodynamic therapy the treatment of choice in long-lasting CSC¹⁰.

In a trial of 179 people with long-lasting CSC, fluid had cleared at the final check in about 67 of every 100 given half-dose photodynamic therapy, against about 29 of every 100 given a micropulse laser¹¹. That is a meaningful difference from one well-run trial. Availability of the drug varies by country and year, so ask what your clinic can offer.

Other approaches are still used in particular situations. Thermal laser can be aimed at a leak sitting away from the very center, and micropulse laser delivers gentler pulses. Tablets have been tried, with disappointing results in the one large trial.

In a trial of 114 adults with long-lasting CSC, the tablet eplerenone was no better than a dummy tablet for vision at 12 months¹². Across 25 randomized trials with 1,098 participants, no single treatment showed convincing superiority and the certainty of the evidence was mostly low⁸. That uncertainty is why your specialist weighs how long fluid has been there against how much it affects you.

Often it improves, but nobody can promise a particular result for your eye. Most sudden episodes clear within three to six months whether or not a steroid was involved³, and stopping the steroid where that is medically possible is part of standard management³. Some people are left with mild distortion or dimness. The decision about stopping belongs with the doctor who prescribed it, because the condition it treats still has to be handled.

Nose sprays are on the list. Pooled data found the link with CSC held for nasal-spray steroids, while the result for inhaled steroids was not statistically clear². Retina specialists name allergy nose sprays among the steroid exposures worth reporting¹. This is not a reason to abandon an inhaler that controls your asthma. It is a reason to list every steroid you use when your eyes are assessed.

It can be. CSC has been reported after steroid injections into joints and near the spine, as well as injections given around the eye³. In pooled data, injected steroids showed the same direction of association as tablets². One injection is not something most people need to refuse. Mention it at your eye appointment, especially if you have had CSC before, so your team can factor it in.

That is a question for your surgeon, and it usually has a workable answer. Steroid drops after eye surgery serve a real purpose, and the choice of drop and the schedule can often be adjusted for someone with a CSC history. Raise your CSC well before the operation rather than on the day, so your surgeon can plan the drops and arrange a scan afterwards if that seems sensible.

Both sit on the risk list and are hard to separate. The review of 17 studies found links with steroid use, poor sleep, and a driven, time-pressured personality style, among others⁷. Stress raises your own cortisol, the same hormone family as the medicine, so the two may act through one pathway. Practically, you can review a medicine with your doctor and work on sleep. Both are reasonable.

Often not, but it happens. CSC usually affects one eye at a time¹, though steroid-linked cases involved both eyes more often than cases without steroid exposure in a multicenter comparison⁹. Your other eye usually compensates well meanwhile. That is also why checking each eye separately at home is worth the minute, since a change in the second eye is easy to miss.